Asymbescaline  |
 |
| Names |
| IUPAC name 3,4-Diethoxy-5-methoxyphenethylamine |
| Other names 2-(3,4-Diethoxy-5-methoxyphenyl)ethanamine |
| Identifiers |
| | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| | |
| | |
InChI=1S/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3  Key: VFOAVFQWZYUFQZ-UHFFFAOYSA-N InChI=1/C13H21NO3/c1-4-16-12-9-10(6-7-14)8-11(15-3)13(12)17-5-2/h8-9H,4-7,14H2,1-3H3 Key: VFOAVFQWZYUFQZ-UHFFFAOYAI
|
SMILES O(c1c(OC)cc(cc1OCC)CCN)CC
|
| Properties |
| | C13H21NO3 |
| Molar mass | 239.315 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
| | |
Asymbescaline (3,4-diethoxy-5-methoxyphenethylamine) is a lesser-known psychedelic drug. It is a homolog of mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 200–280 mg, and the duration listed as 10–15 hours.[1] Asymbescaline produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of asymbescaline.
See also
References
This article is copied from an
article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of
GNU Free Documentation License.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
)
)
